27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

      Cell
      Adenosine Triphosphate, metabolism, Amino Acid Sequence, Animals, Cells, Cultured, Cysteine Endopeptidases, drug effects, DNA-Binding Proteins, Humans, I-kappa B Proteins, Leupeptins, pharmacology, Models, Biological, Molecular Sequence Data, Multienzyme Complexes, NF-kappa B, biosynthesis, NF-kappa B p50 Subunit, Protease Inhibitors, Proteasome Endopeptidase Complex, Protein Precursors, Protein Processing, Post-Translational, Ubiquitins

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We demonstrate an essential role for the proteasome complex in two proteolytic processes required for activation of the transcription factor NF-kappa B. The p105 precursor of the p50 subunit of NF-kappa B is processed in vitro by an ATP-dependent process that requires proteasomes and ubiquitin conjugation. The C-terminal region of p105 is rapidly degraded, leaving the N-terminal p50 domain. p105 processing can be blocked in intact cells with inhibitors of the proteasome or in yeast with proteasome mutants. These inhibitors also block the activation of NF-kappa B and the rapid degradation of I kappa B alpha induced by tumor necrosis factor alpha. Thus, the ubiquitin-proteasome pathway functions not only in the complete degradation of polypeptides, but also in the regulated processing of precursors into active proteins.

          Related collections

          Author and article information

          Comments

          Comment on this article